Callan Capital LLC Invests $251,000 in Sanofi (NASDAQ:SNY)

Callan Capital LLC acquired a new stake in shares of Sanofi (NASDAQ:SNY) in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund acquired 5,167 shares of the company’s stock, valued at approximately $251,000.

A number of other institutional investors have also recently added to or reduced their stakes in the stock. Cardinal Capital Management increased its stake in shares of Sanofi by 0.3% during the fourth quarter. Cardinal Capital Management now owns 58,854 shares of the company’s stock valued at $2,927,000 after acquiring an additional 201 shares during the period. Daiwa Securities Group Inc. increased its position in shares of Sanofi by 3.4% during the 4th quarter. Daiwa Securities Group Inc. now owns 6,541 shares of the company’s stock valued at $325,000 after purchasing an additional 216 shares during the period. Wynn Capital LLC raised its stake in shares of Sanofi by 4.5% in the 1st quarter. Wynn Capital LLC now owns 5,266 shares of the company’s stock worth $256,000 after buying an additional 226 shares in the last quarter. Angeles Investment Advisors LLC raised its stake in shares of Sanofi by 2.1% in the 4th quarter. Angeles Investment Advisors LLC now owns 12,029 shares of the company’s stock worth $598,000 after buying an additional 244 shares in the last quarter. Finally, Rise Advisors LLC lifted its holdings in shares of Sanofi by 98.4% in the fourth quarter. Rise Advisors LLC now owns 506 shares of the company’s stock valued at $25,000 after buying an additional 251 shares during the period. 10.04% of the stock is currently owned by institutional investors.

Sanofi Price Performance

SNY stock traded up $0.96 during trading hours on Wednesday, hitting $51.03. 3,369,260 shares of the stock traded hands, compared to its average volume of 2,146,859. The company has a current ratio of 1.27, a quick ratio of 0.87 and a debt-to-equity ratio of 0.19. The stock has a 50-day simple moving average of $48.78 and a 200 day simple moving average of $48.61. Sanofi has a one year low of $42.63 and a one year high of $55.72. The company has a market cap of $129.25 billion, a P/E ratio of 25.16, a P/E/G ratio of 1.56 and a beta of 0.59.

Sanofi (NASDAQ:SNY) last announced its quarterly earnings data on Thursday, April 25th. The company reported $0.96 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.96. Sanofi had a net margin of 10.52% and a return on equity of 26.25%. The company had revenue of $11.36 billion for the quarter, compared to analysts’ expectations of $11.75 billion. Equities analysts forecast that Sanofi will post 4.14 earnings per share for the current year.

About Sanofi

Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through Pharmaceuticals, Vaccines, and Consumer Healthcare segments. The company provides specialty care, such as DUPIXENT, neurology and immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes and cardiovascular diseases; and established prescription products.